help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on December 9, 2005, doi:10.1165/rcmb.2005-0170OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0170OCv1
34/4/399    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lau, Y. E.
Right arrow Articles by Davidson, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lau, Y. E.
Right arrow Articles by Davidson, D. J.
American Journal of Respiratory Cell and Molecular Biology. Vol. 34, pp. 399-409, 2006
© 2006 American Thoracic Society
DOI: 10.1165/rcmb.2005-0170OC

Apoptosis of Airway Epithelial Cells

Human Serum Sensitive Induction by the Cathelicidin LL-37

Y. Elaine Lau, Dawn M. E. Bowdish, Celine Cosseau, Robert E. W. Hancock and Donald J. Davidson*

Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada

Correspondence and requests for reprints should be addressed to Dr. R. E. W. Hancock, Centre for Microbial Diseases and Immunity Research, Room 232, 2259 Lower Mall Research Station, University of British Columbia, Vancouver, BC, V6T 1Z4 Canada. E-mail: bob{at}cmdr.ubc.ca

LL-37 is a human cationic host defense peptide that is present in the specific granules of neutrophils, produced by epithelial cells from a variety of tissues, and is upregulated during inflammation, infection, and injury. It has been proposed to have a variety of antimicrobial functions, including both direct antimicrobial activity and immunomodulatory functions. Using the TUNEL assay it was demonstrated that LL-37 induced apoptosis in vitro in the A549 human lung and 16HBE4o- human airway epithelial cell lines, and in vivo in the murine airway. Peptide-induced apoptosis in vitro involved the activation of caspase pathways and was substantially inhibited by an inhibitor of caspase 3. Apoptosis was also inhibited by human serum, but not fetal bovine serum. Similarly, human but not fetal bovine serum inhibited the cellular internalization of LL-37 and the production of IL-8 in response to LL-37 treatment of epithelial cells. The protective effects of human serum were also observed with high-density lipoproteins but not by the core peptide apolipoprotein A1, providing one possible mechanism of human serum inhibition of apoptosis. We propose that LL-37–induced apoptosis of epithelial cells at low serum tissue sites may have a protective role against bacterial infection.

Key Words: apoptosis • cathelicidin • epithelial cells • host defense peptide • LL-37




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
H.-N. Li, P. G. Barlow, J. Bylund, A. Mackellar, A. Bjorstad, J. Conlon, P. S. Hiemstra, C. Haslett, M. Gray, A. J. Simpson, et al.
Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages
J. Leukoc. Biol., October 1, 2009; 86(4): 891 - 902.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Mookherjee, D. N. D. Lippert, P. Hamill, R. Falsafi, A. Nijnik, J. Kindrachuk, J. Pistolic, J. Gardy, P. Miri, M. Naseer, et al.
Intracellular Receptor for Human Host Defense Peptide LL-37 in Monocytes
J. Immunol., August 15, 2009; 183(4): 2688 - 2696.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Chakraborty, P. C. Maity, A. K. Sil, Y. Takeda, and S. Das
cAMP Stringently Regulates Human Cathelicidin Antimicrobial Peptide Expression in the Mucosal Epithelial Cells by Activating cAMP-response Element-binding Protein, AP-1, and Inducible cAMP Early Repressor
J. Biol. Chem., August 14, 2009; 284(33): 21810 - 21827.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. S. Mader, N. Mookherjee, R. E.W. Hancock, and R. C. Bleackley
The Human Host Defense Peptide LL-37 Induces Apoptosis in a Calpain- and Apoptosis-Inducing Factor-Dependent Manner Involving Bax Activity
Mol. Cancer Res., May 1, 2009; 7(5): 689 - 702.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. Bjorstad, G. Askarieh, K. L. Brown, K. Christenson, H. Forsman, K. Onnheim, H.-N. Li, S. Teneberg, O. Maier, D. Hoekstra, et al.
The Host Defense Peptide LL-37 Selectively Permeabilizes Apoptotic Leukocytes
Antimicrob. Agents Chemother., March 1, 2009; 53(3): 1027 - 1038.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Z. Zhang, G. Cherryholmes, and J. E. Shively
Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin
J. Leukoc. Biol., September 1, 2008; 84(3): 780 - 788.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Bozue, K. L. Moody, C. K. Cote, B. G. Stiles, A. M. Friedlander, S. L. Welkos, and M. L. Hale
Bacillus anthracis Spores of the bclA Mutant Exhibit Increased Adherence to Epithelial Cells, Fibroblasts, and Endothelial Cells but Not to Macrophages
Infect. Immun., September 1, 2007; 75(9): 4498 - 4505.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. G. Barlow, Y. Li, T. S. Wilkinson, D. M. E. Bowdish, Y. E. Lau, C. Cosseau, C. Haslett, A. J. Simpson, R. E. W. Hancock, and D. J. Davidson
The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system
J. Leukoc. Biol., September 1, 2006; 80(3): 509 - 520.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Pochet, S. Tandel, S. Querriere, M. Tre-Hardy, M. Garcia-Marcos, M. De Lorenzi, M. Vandenbranden, A. Marino, M. Devleeschouwer, and J.-P. Dehaye
Modulation by LL-37 of the Responses of Salivary Glands to Purinergic Agonists
Mol. Pharmacol., June 1, 2006; 69(6): 2037 - 2046.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society.
  2nd Annual Dinner